{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06488560",
            "orgStudyIdInfo": {
                "id": "HSC-MS-24-0047"
            },
            "organization": {
                "fullName": "The University of Texas Health Science Center, Houston",
                "class": "OTHER"
            },
            "briefTitle": "The Impact of Commercial Blenderized Formula on Caloric Needs, Gastrointestinal Symptoms, and Gut Microbiome in Children With Cerebral Palsy (CP)",
            "officialTitle": "The Impact of Commercial Blenderized Formula on Caloric Needs, Gastrointestinal Symptoms, and Gut Microbiome in Children With Cerebral Palsy: A Single Center Randomized Open Label Clinical Trial",
            "therapeuticArea": [
                "Other"
            ],
            "study": "the-impact-of-commercial-blenderized-formula-on-caloric-needs-gastrointestinal-symptoms-and-gut-microbiome-in-children-with-cerebral-palsy-cp"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-08-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-05-07",
            "studyFirstSubmitQcDate": "2024-06-27",
            "studyFirstPostDateStruct": {
                "date": "2024-07-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-27",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Fernando Navarro",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "The University of Texas Health Science Center, Houston"
            },
            "leadSponsor": {
                "name": "The University of Texas Health Science Center, Houston",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to compare the Pediatric Quality of Life Inventory Gastrointestinal Symptoms Scale Gastrointestinal Symptoms Scale (GI-PedsQL) differences , to assess the differences in stool microbiome and stool metabolomics , to assess differences in salivary cytokine profile , to assess differences in weight change , to compare the use of antacid medications and to compare the use of laxative medications in patients on commercial formulas (CF) versus commercial blenderized tube feed (CBTF)."
        },
        "conditionsModule": {
            "conditions": [
                "Cerebral Palsy"
            ],
            "keywords": [
                "Blenderized tube feeds (BTF)",
                "commercial blenderized tube feed (CBTF)",
                "Commercial formula"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "commercial blenderized tube feed (CBTF)",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Dietary Supplement: commercial blenderized tube feed (CBTF)"
                    ]
                },
                {
                    "label": "commercial formulas (CF)",
                    "type": "ACTIVE_COMPARATOR",
                    "interventionNames": [
                        "Dietary Supplement: commercial formulas (CF)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "commercial blenderized tube feed (CBTF)",
                    "description": "Based on assessment by a dietician the participant will be fed the commercial blenderized formula to meet their caloric needs",
                    "armGroupLabels": [
                        "commercial blenderized tube feed (CBTF)"
                    ]
                },
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "commercial formulas (CF)",
                    "description": "Participant will be fed the commercial formula to meet their caloric needs per standard of care",
                    "armGroupLabels": [
                        "commercial formulas (CF)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in quality of life as assessed by the Pediatric QoL Inventory of GI Symptom Scale.",
                    "description": "This is a 74 item questionnaire and each is scored from 0 (never) to 4 (almost always), higher score indicating worse outcome.",
                    "timeFrame": "Baseline, end of study (2 months after baseline)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in fecal samples for microbiome analysis (identity, composition, and relative abundance of bacterial taxa in stool specimens)",
                    "timeFrame": "Baseline, end of study (2 months after baseline)"
                },
                {
                    "measure": "Change in stool metabolomic profile",
                    "description": "Mass spectrometry will be used to assess the following metabolites: amino acids, methylated metabolites, bile acids, and nucleotides.",
                    "timeFrame": "Baseline, end of study (2 months after baseline)"
                },
                {
                    "measure": "Change in salivary cytokine profile",
                    "description": "Gene expression of the following salivary inflammatory cytokines will be assessed: interleukin-8 (IL-8), toll-like receptor 8 (TLR8), interleukin-26 (IL-26), interleukin-22 (IL-22), C-C motif chemokine receptor type 1 (CCR1), Caspase 2 (CASP2), toll-like receptor 8 (TLR8), and Intercellular adhesion molecule 3 (ICAM3).",
                    "timeFrame": "Baseline, end of study (2 months after baseline)"
                },
                {
                    "measure": "Change in stool caliber using the Bristol stool scale",
                    "description": "The Bristol stool scale categorizes stool into one of 7 types, as follows. Types 1 and 2 indicate constipation, with 3 and 4 being the ideal stools as they are easy to defecate while not containing excess liquid, and 6 and 7 indicate diarrhea.\n\nType 1: Separate hard lumps, like nuts (difficult to pass) Type 2: Sausage-shaped, but lumpy Type 3: Like a sausage but with cracks on its surface Type 4: Like a sausage or snake, smooth and soft (average stool) Type 5: Soft blobs with clear cut edges Type 6: Fluffy pieces with ragged edges, a mushy stool (diarrhea) Type 7: Watery, no solid pieces, entirely liquid (diarrhea)",
                    "timeFrame": "Baseline, end of study (2 months after baseline)"
                },
                {
                    "measure": "Number of participants who needed to add or remove antacid or laxative medications from their bowel regimen",
                    "description": "Medications in the bowel regimen include antacids and laxatives.",
                    "timeFrame": "Baseline, end of study (2 months after baseline)"
                },
                {
                    "measure": "Number of participants who had dose adjustments to their antacid or laxative medications",
                    "timeFrame": "Baseline, end of study (2 months after baseline)"
                },
                {
                    "measure": "Change in weight",
                    "timeFrame": "Baseline, end of study (2 months after baseline)"
                },
                {
                    "measure": "Change in weight percentile",
                    "timeFrame": "Baseline, end of study (2 months after baseline)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with CP receiving \\>75% of total daily caloric requirements from commercial formulas (CF) via a gastrostomy tube 12french or greater\n* Patients' insurance covers a CBTF\n* Diagnosis of cerebral palsy\n\nExclusion Criteria:\n\n* Receiving enteral nutrition by transpyloric feeds or jejunal tube.\n* Receiving \\<75% of total daily energy requirements from a commercial formula\n* Weight or weight for length or body mass index less than the 5th percentile for age or greater than the 85th% percentile for age when plotted on the cerebral palsy growth chart\n* Rapidly progressive neurodegenerative disease diagnosis\n* Use of monomeric formulas",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "3 Years",
            "maximumAge": "18 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Fernando Navarro, MD",
                    "role": "CONTACT",
                    "phone": "(713) 500-5663",
                    "email": "Fernando.Navarro@uth.tmc.edu"
                },
                {
                    "name": "Ana F Alvarez",
                    "role": "CONTACT",
                    "phone": "(713) 500-5663",
                    "email": "Ana.B.FadhelAlvarez@uth.tmc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Fernando Navarro",
                    "affiliation": "The University of Texas Health Science Center, Houston",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "The University of Texas Health Science Center at Houston",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Fernando Navarro, MD",
                            "role": "CONTACT",
                            "phone": "713-500-5663",
                            "email": "Fernando.Navarro@uth.tmc.edu"
                        },
                        {
                            "name": "Ana F Alvarez",
                            "role": "CONTACT",
                            "phone": "(713) 500-5663",
                            "email": "Ana.B.FadhelAlvarez@uth.tmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002547",
                    "term": "Cerebral Palsy"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000001925",
                    "term": "Brain Damage, Chronic"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5796",
                    "name": "Cerebral Palsy",
                    "asFound": "Cerebral Palsy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13157",
                    "name": "Paralysis",
                    "relevance": "LOW"
                },
                {
                    "id": "M5207",
                    "name": "Brain Injuries",
                    "relevance": "LOW"
                },
                {
                    "id": "M5202",
                    "name": "Brain Damage, Chronic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}